Legal Representation
Attorney
David R. Kelly
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 7, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Feb 7, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Nov 28, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 28, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 31, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 31, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 31, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 31, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 31, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 13, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 12, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 8, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Apr 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 20, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 20, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 20, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 22, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 20, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 20, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 20, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 17, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 15, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 15, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 15, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 11, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 10, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 10, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 8, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 8, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 8, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 19, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 10, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 21, 2018 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jun 21, 2018 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Dec 21, 2017 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 21, 2017 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 21, 2017 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 6, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 5, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 5, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 5, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 5, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 16, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression
Class 005
Chemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders
Class 042
Scientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease which are under development or have completed development; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use
Class 044
Medical services; Medical services, namely, genetic engineering, biopharmaceuticals and gene therapy services; Healthcare services, namely, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; Medical services, namely, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases
Class 045
Technology transfer services, namely, licensing of intellectual property
Classification
International Classes
001
005
042
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"